The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk

Journal of Steroid Biochemistry and Molecular Biology

Volumn 126, Issue 3-5, 2011, Pages 78-86

  Williams Brown, Marian Y ^a   Salih, Sana M ^b   Xu, Xia ^c   Veenstra, Timothy D ^c   Saeed, Muhammad ^d   Theiler, Shaleen K ^a,e   Diaz Arrastia, Concepcion R ^a,e   Salama, Salama A ^a,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Endometrial cancer; Estrogen metabolism; Raloxifene; Tamoxifen

Indexed keywords

16 OXOESTRADIOL; 16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 4 METHOXYESTRADIOL; ANTIESTROGEN; ANTINEOPLASTIC AGENT; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DRUG METABOLITE; EPIESTRIOL; EPIMESTROL; ESTRADIOL; ESTROGEN; ESTRONE; RALOXIFENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); STEROIDOGENIC FACTOR 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RISK; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA ADDUCT; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENDOMETRIUM CANCER; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FEMALE; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROXYLATION; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING;

CARCINOMA; CELLS, CULTURED; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; RALOXIFENE; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 79959797981     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.05.001     Document Type: Article

References (55)

1. I. Cohen Endometrial pathologies associated with postmenopausal tamoxifen treatment Gynecol. Oncol. 94 2004 256 266 (Pubitemid 39024525)
2. P. Neven, and I. Vergote Controversies regarding tamoxifen and uterine carcinoma Curr. Opin. Obstet. Gynecol. 10 1998 9 14 (Pubitemid 28079415)
3. B.M. Slomovitz, C.C. Sun, P.T. Ramirez, D.C. Bodurka, P. Diaz, and K.H. Lu Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet. Gynecol. 104 2004 255 260 (Pubitemid 40458869)
4. A. DeMichele, A.B. Troxel, J.A. Berlin, A.L. Weber, G.R. Bunin, E. Turzo, R. Schinnar, D. Burgh, M. Berlin, S.C. Rubin, T.R. Rebbeck, and B.L. Strom Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study J. Clin. Oncol. 26 2008 4151 4159
5. K. Hemminki, H. Rajaniemi, B. Lindahl, and B. Moberger Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients Cancer Res. 56 1996 4374 4377 (Pubitemid 26330442)
6. S. Shibutani, N. Suzuki, I. Terashima, S.M. Sugarman, A.P. Grollman, and M.L. Pearl Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen Chem. Res. Toxicol. 12 1999 646 653 (Pubitemid 29354748)
7. S. Shibutani, A. Ravindernath, N. Suzuki, I. Terashima, S.M. Sugarman, A.P. Grollman, and M.L. Pearl Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen Carcinogenesis 21 2000 1461 1467 (Pubitemid 30601641)
8. A. Umemoto, Y. Monden, C.X. Lin, M. bdul-Momen, Y. Ueyama, K. Komaki, Y.R. Laxmi, and S. Shibutani Determination of tamoxifen-DNA adducts in leukocytes from breast cancer patients treated with tamoxifen Chem. Res. Toxicol. 17 2004 1577 1583 (Pubitemid 39665548)
9. S.Y. Kim, N. Suzuki, Y.R. Laxmi, and S. Shibutani Genotoxic mechanism of tamoxifen in developing endometrial cancer Drug Metab. Rev. 36 2004 199 218 (Pubitemid 38802486)
10. K. Brown Is tamoxifen a genotoxic carcinogen in women? Mutagenesis 24 2009 391 404
11. A. Besaratinia, and G.P. Pfeifer Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells Biochemistry 44 2005 8418 8427 (Pubitemid 40799922)
12. E. Liapis, K.I. McLuckie, P.D. Lewis, P.B. Farmer, and K. Brown Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots Nucleic Acids Res. 36 2008 5933 5945
13. P.L. Carmichael, S. Sardar, N. Crooks, P. Neven, H.I. Van, A. Ugwumadu, T. Bourne, E. Tomas, P. Hellberg, A.J. Hewer, and D.H. Phillips Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium Carcinogenesis 20 1999 339 342 (Pubitemid 29057570)
14. P.L. Carmichael, A.H. Ugwumadu, P. Neven, A.J. Hewer, G.K. Poon, and D.H. Phillips Lack of genotoxicity of tamoxifen in human endometrium Cancer Res. 56 1996 1475 1479 (Pubitemid 26104004)
15. F.A. Beland, M.I. Churchwell, D.R. Doerge, D.R. Parkin, D. Malejka-Giganti, A. Hewer, D.H. Phillips, P.L. Carmichael, C.G. Gamboa da, and M.M. Marques Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans J. Natl. Cancer Inst. 96 2004 1099 1104 (Pubitemid 39172412)
16. D.H. Phillips, A. Hewer, P.L. Grover, G.K. Poon, and P.L. Carmichael Tamoxifen does not form detectable DNA adducts in white blood cells of breast cancer patients Carcinogenesis 17 1996 1149 1152 (Pubitemid 26158417)
17. H. Bartsch, D.H. Phillips, J. Nair, A. Hewer, G. Meyberg-Solomeyer, and E.M. Grischke Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients Carcinogenesis 21 2000 845 847 (Pubitemid 30214047)
18. L. Morales, D. Timmerman, P. Neven, M.L. Konstantinovic, A. Carbonez, H.S. Van, L. Ameye, C. Weltens, M.R. Christiaens, I. Vergote, and R. Paridaens Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients Ann. Oncol. 16 2005 70 74 (Pubitemid 40124481)
19. L. Morales, R. Paridaens, D. Timmerman, and P. Neven Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology Clin. Cancer Res. 12 2006 5603 (Pubitemid 44497279)
20. M. Prasad, H. Wang, W. Douglas, R.R. Barakat, and L.H. Ellenson Molecular genetic characterization of tamoxifen-associated endometrial cancer Gynecol. Oncol. 96 2005 25 31 (Pubitemid 39612413)
21. S.A. Salama, M. Kamel, M. Awad, A.H. Nasser, A. Al-Hendy, S. Botting, and C. Arrastia Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase Int. J. Cancer 123 2008 1246 1254
22. B.C. Lin, M. Suzawa, R.D. Blind, S.C. Tobias, S.E. Bulun, T.S. Scanlan, and H.A. Ingraham Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation Cancer Res. 69 2009 5415 5423
23. V. Speirs, E.F. Adams, and M.C. White The anti-estrogen tamoxifen blocks the stimulatory effects of interleukin-6 on 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells J. Steroid Biochem. Mol. Biol. 46 1993 605 611 (Pubitemid 23346144)
24. S.J. Santner, and R.J. Santen Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens J. Steroid Biochem. Mol. Biol. 45 1993 383 390 (Pubitemid 23163015)
25. M.M. Montano, N.R. Bianco, H. Deng, B.M. Wittmann, L.C. Chaplin, and B.S. Katzenellenbogen Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen Front. Biosci. 10 2005 1440 1461
26. P.G. Allen, and J.M. Kolesar NAD(P)H: quinone oxidoreductase enhances proliferation inhibition by 4-hydroxytamoxifen Anticancer Res. 22 2002 1475 1480 (Pubitemid 34839153)
27. I. Campisi, O.M. Granata, L. Cocciadiferro, M. Calabro, L.M. Polito, and G. Carruba 16alpha-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells Ann. N.Y. Acad. Sci. 1155 2009 237 241
28. S. Kyo, M. Nakamura, T. Kiyono, Y. Maida, T. Kanaya, M. Tanaka, N. Yatabe, and M. Inoue Successful immortalization of endometrial glandular cells with normal structural and functional characteristics Am. J. Pathol. 163 2003 2259 2269 (Pubitemid 37466470)
29. X. Xu, L.K. Keefer, R.G. Ziegler, and T.D. Veenstra A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites Nat. Protocol 2 2007 1350 1355 (Pubitemid 46952316)
30. M. Zahid, N.W. Gaikwad, M.F. Ali, F. Lu, M. Saeed, L. Yang, E.G. Rogan, and E.L. Cavalieri Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol Free Radic. Biol. Med. 45 2008 136 145
31. A.H. Eliassen, R.G. Ziegler, B. Rosner, T.D. Veenstra, J.M. Roman, X. Xu, and S.E. Hankinson Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women Cancer Epidemiol. Biomarkers Prev. 18 2009 2860 2868
32. Y. Shang, and M. Brown Molecular determinants for the tissue specificity of SERMs Science 295 2002 2465 2468 (Pubitemid 34270263)
33. Y. Shang Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis Nat. Rev. Cancer 6 2006 360 368
34. H.L. Bradlow, R.J. Hershcopf, C.P. Martucci, and J. Fishman Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans Proc. Natl. Acad. Sci. U.S.A. 82 1985 6295 6299 (Pubitemid 16222871)
35. A.O. Mueck, and H. Seeger Breast cancer: are estrogen metabolites carcinogenic? Climacteric 10 Suppl. 2 2007 62 65 (Pubitemid 47450838)
36. M.J. Scandlyn, E.C. Stuart, T.J. Somers-Edgar, A.R. Menzies, and R.J. Rosengren A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate Br. J. Cancer 99 2008 1056 1063
37. S.S. Lee, H.G. Jeong, and K.H. Yang Effects of estradiol and progesterone on cytochrome P4501A1 expression in Hepa 1c1c7 cells Biochem. Mol. Biol. Int. 45 1998 775 781 (Pubitemid 28393546)
38. M.S. Ricci, D.G. Toscano, C.J. Mattingly, and W.A. Toscano Jr. Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells J. Biol. Chem. 274 1999 3430 3438 (Pubitemid 29077182)
39. B.J. Fuhrman, X. Xu, R.T. Falk, S.E. Hankinson, T.D. Veenstra, L.K. Keefer, and R.G. Ziegler Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies Int. J. Biol. Markers 25 2010 185 194
40. M. Maggiolini, A. Vivacqua, G. Fasanella, A.G. Recchia, D. Sisci, V. Pezzi, D. Montanaro, A.M. Musti, D. Picard, and S. Ando The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells J. Biol. Chem. 279 2004 27008 27016 (Pubitemid 38812536)
41. E.J. Filardo, J.A. Quinn, A.R. Frackelton Jr., and K.I. Bland Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis Mol. Endocrinol. 16 2002 70 84 (Pubitemid 34044499)
42. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 2005 1625 1630 (Pubitemid 40354745)
43. A. Sourla, S. Luo, C. Labrie, A. Belanger, and F. Labrie Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800 Endocrinology 138 1997 5605 5617 (Pubitemid 27509727)
44. S. Luo, C. Martel, A. Sourla, S. Gauthier, Y. Merand, A. Belanger, C. Labrie, and F. Labrie Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice Int. J. Cancer 73 1997 381 391 (Pubitemid 27508901)
45. B.T. Zhu, and A.H. Conney Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1998 1 27 (Pubitemid 28376821)
46. J.A. Doherty, N.S. Weiss, R.J. Freeman, D.A. Dightman, P.J. Thornton, J.R. Houck, L.F. Voigt, M.A. Rossing, S.M. Schwartz, and C. Chen Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer Cancer Epidemiol. Biomarkers Prev. 14 2005 357 366 (Pubitemid 40270097)
47. E. Taioli, A. Im, X. Xu, T.D. Veenstra, G. Ahrendt, and S. Garte Comparison of estrogens and estrogen metabolites in human breast tissue and urine Reprod. Biol. Endocrinol. 8 2010 93
48. Y. Tsuchiya, N. Nakajima, S. Kyo, T. Kanaya, M. Inoue, and T. Yokoi Human CYP1B1 is regulated by estradiol via estrogen receptor Cancer Res. 64 2004 3119 3125 (Pubitemid 38581412)
49. S. Harmsen, I. Meijerman, J.H. Beijnen, and J.H. Schellens Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor Cancer Chemother. Pharmacol. 64 2009 35 43
50. R.S. Sane, D.J. Buckley, A.R. Buckley, S.C. Nallani, and P.B. Desai Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells Drug Metab. Dispos. 36 2008 946 954 (Pubitemid 351574894)
51. S.P. Sripathy, L.J. Chaplin, N.W. Gaikwad, E.G. Rogan, and M.M. Montano hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen Oncogene 27 2008 6376 6384
52. T.M. Kian, I. Rogatsky, C. Tzagarakis-Foster, A. Cvoro, J. An, R.J. Christy, K.R. Yamamoto, and D.C. Leitman Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta Mol. Biol. Cell 15 2004 1262 1272 (Pubitemid 38316233)
53. B.S. Katzenellenbogen, and J.A. Katzenellenbogen Biomedicine. Defining the "S" in SERMs Science 295 2002 2380 2381
54. M.M. Montano, H. Deng, M. Liu, X. Sun, and R. Singal Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications Oncogene 23 2004 2442 2453 (Pubitemid 38520742)
55. W.J. Welboren, H.G. Stunnenberg, F.C. Sweep, and P.N. Span Identifying estrogen receptor target genes Mol. Oncol. 1 2007 138 143 (Pubitemid 47199132)